dipyridamole has been researched along with Hernias, Diaphragmatic, Congenital in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hernias, Diaphragmatic, Congenital: Protrusion of abdominal structures into the THORAX as a result of embryologic defects in the DIAPHRAGM often present in the neonatal period. It can be isolated, syndromic, non-syndromic or be a part of chromosome abnormality. Associated pulmonary hypoplasia and PULMONARY HYPERTENSION can further complicate stabilization and surgical intervention.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Congenital diaphragmatic hernia (CDH) remains a frustrating cause of respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN)." | 1.30 | Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia. ( Farnoux, C; Hartman, JF; Mercier, JC; Saizou, C; Thébaud, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thébaud, B | 2 |
| Saizou, C | 1 |
| Farnoux, C | 1 |
| Hartman, JF | 1 |
| Mercier, JC | 2 |
| de Lagausie, P | 1 |
| Forgues, D | 1 |
| Aigrain, Y | 1 |
| Dinh-Xuan, AT | 1 |
| Buysse, C | 1 |
| Fonteyne, C | 1 |
| Dessy, H | 1 |
| De Laet, MH | 1 |
| Biarent, D | 1 |
3 other studies available for dipyridamole and Hernias, Diaphragmatic, Congenital
| Article | Year |
|---|---|
Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia.
Topics: Administration, Inhalation; Dipyridamole; Fatal Outcome; Hernia, Diaphragmatic; Hernias, Diaphragmat | 1999 |
ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Cyclic GMP; Dipyridamole; Disease Models, Animal; E | 2000 |
The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia.
Topics: Dipyridamole; Extracorporeal Membrane Oxygenation; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Co | 2001 |